Hot Pursuit     07-Apr-22
Alembic Pharmaceuticals Ltd spurts 2.6%, rises for fifth straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 779.8, up 2.6% on the day as on 12:49 IST on the NSE. The stock is down 19.86% in last one year as compared to a 19.38% jump in NIFTY and a 9.61% jump in the Nifty Pharma.

Alembic Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 779.8, up 2.6% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.29% on the day, quoting at 17756.25. The Sensex is at 59387.21, down 0.37%. Alembic Pharmaceuticals Ltd has gained around 8.91% in last one month.

Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has gained around 7.62% in last one month and is currently quoting at 13758.45, up 0.48% on the day. The volume in the stock stood at 3.77 lakh shares today, compared to the daily average of 2.63 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 782, up 2.64% on the day. Alembic Pharmaceuticals Ltd is down 19.86% in last one year as compared to a 19.38% jump in NIFTY and a 9.61% jump in the Nifty Pharma index.

The PE of the stock is 19.32 based on TTM earnings ending December 21.

Previous News
  Alembic Pharmaceuticals reports consolidated net profit of Rs 120.60 crore in the June 2023 quarter
 ( Results - Announcements 04-Aug-23   14:15 )
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Volumes soar at Timken India Ltd counter
 ( Hot Pursuit - 30-Nov-23   11:00 )
  Camlin Fine Sciences Ltd leads gainers in 'A' group
 ( Hot Pursuit - 30-Nov-23   12:00 )
  Alembic Pharma gets tentative USFDA nod for Brexpiprazole tablets
 ( Hot Pursuit - 09-Mar-23   09:18 )
  Alembic Pharmaceuticals receives USFDA approval for various products
 ( Corporate News - 09-May-24   09:01 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Alembic Pharma gets USFDA nod for Nifedipine tablets
 ( Hot Pursuit - 21-Nov-22   11:14 )
  Alembic Pharmaceuticals receives USFDA approval for Cyclophosphamide Capsules
 ( Corporate News - 14-Nov-22   09:11 )
  Alembic Pharmaceuticals receives USFDA approval for Nifedipine Extended-Release Tablets
 ( Corporate News - 21-Nov-22   10:52 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 22-Jul-23   11:01 )
Other Stories
  Volumes jump at Vijaya Diagnostic Centre Ltd counter
  30-Sep-24   14:30
  Banking shares fall
  30-Sep-24   14:01
  Auto stocks slide
  30-Sep-24   14:01
  Real Estate stocks edge lower
  30-Sep-24   14:00
  Hero MotoCorp Ltd down for fifth straight session
  30-Sep-24   13:36
  Nazara Technologies Ltd slips for fifth straight session
  30-Sep-24   13:36
  Union Bank of India slips for fifth straight session
  30-Sep-24   13:36
  IDFC Ltd soars 1.89%
  30-Sep-24   13:05
  Colgate-Palmolive (India) Ltd up for third consecutive session
  30-Sep-24   13:05
  Hindustan Copper Ltd spurts 1.54%, gains for third straight session
  30-Sep-24   13:05
Back Top